HomeJNY • FRA
Follow
JW (Cayman) Therapeutics Co Ltd
Previous close
€0.23
Year range
€0.18 - €0.33
Market cap
755.75M HKD
Avg Volume
2.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 43.87M | 32.93% |
Operating expense | 176.67M | -2.93% |
Net income | -190.21M | 11.38% |
Net profit margin | -433.57 | 33.33% |
Earnings per share | — | — |
EBITDA | -133.61M | 12.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.27B | -17.88% |
Total assets | 2.65B | -8.38% |
Total liabilities | 511.96M | 74.71% |
Total equity | 2.14B | — |
Shares outstanding | 400.60M | — |
Price to book | 0.04 | — |
Return on assets | -14.54% | — |
Return on capital | -15.24% | — |
Cash Flow
Net change in cash
(CNY) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -190.21M | 11.38% |
Cash from operations | -119.02M | 35.79% |
Cash from investing | 8.76M | 121.37% |
Cash from financing | 44.45M | 801.08% |
Net change in cash | -55.22M | 64.90% |
Free cash flow | -60.87M | 20.33% |
About
CEO
Founded
2016
Website
Employees
398